Aspen Aerogels (ASPN) Current Deferred Revenue (2013 - 2026)

Aspen Aerogels has reported Current Deferred Revenue for 14 years, with the latest figure at $36.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 1282.91% year-over-year to $36.6 million; the trailing twelve-month figure through Mar 2026 stood at $36.6 million (up 1282.91% YoY), and the FY2025 full-year result was $1.3 million, down 42.75% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $36.6 million, up from $1.3 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $36.6 million in Q1 2026, with the low at $624000.0 in Q2 2025.
• Historically, Current Deferred Revenue has averaged $5.0 million across 5 years, with a median of $2.6 million in 2025.
• Annual changes were most pronounced in 2025 — Current Deferred Revenue slumped 79.84% — and 2026, when it jumped 1282.91%.
• Aspen Aerogels' Current Deferred Revenue stood at $5.8 million in 2022, then slumped by 60.38% to $2.3 million in 2023, then fell by 5.05% to $2.2 million in 2024, then plunged by 42.75% to $1.3 million in 2025, then soared by 2805.32% to $36.6 million in 2026.
• The last three Current Deferred Revenue figures came in at $36.6 million (Q1 2026), $1.3 million (Q4 2025), and $824000.0 (Q3 2025), per Business Quant data.